Efficacy of Cystone® versus Tamsulosin in treatment of Stent-Related Lower Urinary Tract Symptoms

Phase 3

Completed

• Conditions: Double- J Stent- Related Lower Urinary Tract Symptoms; Cystone, Tamsulosin, Prostate

• Registration Number: TCTR20200705001
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-12-03
• Study Start: 2020-07-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 128

Inclusion Criteria

Inclusion criteria were the patients who underwent a unilateral Trans Ureteral Lithotripsy (TUL).

Exclusion Criteria

Patients with bilateral Ureteral stone,history of Renal failure, anatomical or functional urological abnormality were excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Double-J Stent-Related Lower Urinary Tract Symptoms Before stent insertion, after 2 weeks, and after 4 weeks The IPSS (International Prostate Symptopm Score)

Secondary Outcome Measures

Name	Time	Method
Pain Before stent insertion, after 2 weeks, and after 4 weeks Visual analogue scale